About
Francisco Leon, MD, PhD, is a biotech entrepreneur and immunologist who founded and leads Tolerance Bio, a company developing thymus-based therapies for immune-mediated disease and healthspan extension. He previously co-founded Provention Bio, where he served as Chief Scientific Officer and held a disclosed founder equity stake, and earlier co-founded Celimmune. Tolerance Bio also says he is co-founder and chairman of Paulex Bio, focused on diabetes prevention and treatment.
Areas of interest
biotechimmunologyautoimmune diseasecell therapyregenerative medicinediabeteslongevityhealthspan